- Zcash Price Prediction August 2026: ZEC Presses Triangle Breakout as DCG Buys Nebraska Mining Site
- European spot electricity prices fall further due to weak demand and increased wind power supply
- Bitcoin spot ETFs pull in $381M this week as buying pressure builds near $64K
- ADVANCED MICRO DEVICES : RAYMOND JAMES RAISES TARGET PRICE TO $565 FROM $455
- WAYFAIR INC. <W.N>: WEDBUSH RAISES TARGET PRICE TO $125 FROM $85
- SPYRE THERAPEUTICS INC <SYRE.O>: WEDBUSH RAISES TARGET PRICE TO $130 FROM $100
- CIVEO CORP <CVEO.N>: RAYMOND JAMES INITIATES COVERAGE WITH STRONG BUY RATING; PRICE TARGET $51
- DIANTHUS THERAPEUTICS INC <DNTH.O>: WEDBUSH RAISES TARGET PRICE TO $122 FROM $105
- Cardiol Therapeutics to join Canaccord Genuity Growth Conference fireside chat
- SIT H1 FY26 EBIT climbs 42.3% to EUR 5.4 million; revenue slips 1.9% to EUR 150.8 million
- 5N PLUS INC. <VNP.TO>: RAYMOND JAMES RAISES TO STRONG BUY FROM OUTPERFORM
- Klabin 2Q26 adjusted EBITDA falls 4% to R$ 1.96 billion; net sales drop 2% to R$ 5.15 billion
- ContextLogic to acquire gChem for USD 850 million
- Solid State announces annual shareholder meeting notice
- Criteo partners with Loblaw Advance as preferred demand partner for Canadian retail media email ads
- The $120 million Coldcard wallet hack triggers activity in the bitcoin mempool.
- Insulet publishes investor presentation outlining Omnipod growth strategy and product pipeline
- Aurora Cannabis Q1 FY2027 adjusted EBITDA drops as Canada medical reimbursement cuts squeeze margins, company says
- SATURN OIL & GAS INC <SOIL.TO>: VENTUM FINANCIAL REINSTATES COVERAGE WITH BUY RATING; TARGET PRICE C$9
- Bitcoin Sentiment Turns Bearish as Negative Commentary Surges
- Rockland Trust names Sep Salimi senior vice president, commercial banking officer
- PINTEREST : ROSENBLATT SECURITIES RAISES TARGET PRICE TO $25 FROM $24
- PEOPLE INCORPORATED : BENCHMARK RAISES TARGET PRICE TO $70 FROM $60
- Rising Demand for Weight Loss Drugs Drives Eli Lilly's Q2 Revenue Up 48% Year-on-Year, Full-Year Revenue Guidance Raised to $85-87 Billion｜Earnings Report Insights
- ARISTA NETWORKS INC : ROSENBLATT SECURITIES RAISES TARGET PRICE TO $280 FROM $210
- After a sharp drop, Sandisk (SNDK.US) rises for two consecutive days—can the financial report confirm the start of an AI storage comeback?
- SanDisk (SNDK.US) rebounds for two consecutive sessions after a sharp decline; can its earnings confirm the start of an AI storage recovery?
- The New York Times’ total subscription revenue for the second quarter was $537.9 million.
- PUMP Above Resistance: Holding This Level Opens the Door to More Upside
post-165496
post-165496
post-165496
- Shopify (SHOP.US) pre-market gains expand to over 30% as second-quarter revenue beats expectations.
- Spot gold has just surpassed the $4,170.00 per ounce mark, now trading at $4,170.17 per ounce, up 2.28% on the day; the main COMEX gold futures contract is now trading at $4,229.40 per ounce, up 1.85% on the day.
- Legacy Gold intersects 1.44 g/t gold over 80 ft in first 2026 RC hole at Baner, Idaho
- NatWest publishes transcript of Q2 2026 results call
- Brink’s Q2 FY26 adjusted EPS rises 18% to 2.13; revenue climbs 7% to 1.39 billion
- Nitches in talks for strategic joint venture with U.S. cGMP manufacturing facility
- Compass Gold reports 8.35 m at 2.82 g/t gold in final Massala drill assays
- Montega reiterates Buy on Bertrandt, sets EUR 18 price target
- REN again makes TIME-Statista list of world’s 500 most sustainable companies for 2026
- Vishay 2Q FY26 diluted EPS rises to 0.19; GAAP revenue climbs to 888.6 million
- ZEBRA TECHNOLOGIES <ZBRA.O>: NEEDHAM RAISES TARGET PRICE TO $410 FROM $345
- WYNN RESORTS, LIMITED <WYNN.O>: STIFEL RAISES TARGET PRICE TO $143 FROM $140
- Rapport Therapeutics Q2 FY26 net loss widens to $56.6 million; R&D expense more than doubled to $51.4 million
- New York Times 2Q Digital-only Subscription Revenues Grew 16.4%>NYT
- Advantage Solutions 2Q Loss/Shr $4.85 >ADV
- Advantage Solutions 2Q Rev $889.5 >ADV
- WORKIVA INC. <WK.N>: STIFEL RAISES TARGET PRICE TO $70 FROM $65
- WATERS CORP <WAT.N>: STIFEL RAISES TARGET PRICE TO $420 FROM $380
- CDW CFO Miralles to retire in 2027, succession search underway
- CS Disco Q2 2026 GAAP net loss narrows to $8.7 million; revenue rises 13% to $43.1 million
- TRAVERE THERAPEUTICS, INC. <TVTX.O>: STIFEL RAISES TARGET PRICE TO $62 FROM $43
- SilverBox Corp. IV extends deadline for Parataxis Holdings deal to Dec. 31, 2026
- Galaxy Digital 2Q Rev $8.56B >GLXY.T
- TRANSMEDICS GROUP, INC. <TMDX.O>: STIFEL CUTS TARGET PRICE TO $65 FROM $80
- THERMO FISHER SCIENTIFIC INC <TMO.N>: STIFEL RAISES TARGET PRICE TO $650 FROM $600
- Kraft Heinz says Q2 2026 results top expectations on U.S. retail, away-from-home, emerging markets strength
- Extreme Networks FY26 GAAP diluted EPS swings to profit of $0.31; revenue rises 12.6% to $1.28 billion
- REVVITY, INC. <RVTY.N>: STIFEL RAISES TARGET PRICE TO $110 FROM $100
- BRIEF-Vishay Intertechnology Q2 Revenue USD 888.575 Million
- Spire Inc Backs FY27 Adj EPS $5.40-Adj EPS $5.60 >SR
- Vishay Intertechnology Sees 3Q Rev $945M-$975M >VSH
- BRIEF-CS Disco Q2 EPS USD -0.13
- GlobalFoundries Q2 FY26 non-IFRS EPS rises 10% Y/Y to USD 0.46; revenue climbs 6% Y/Y to USD 1.79 billion
- CDW declares quarterly cash dividend of $0.63 per share
- New York Times Co posts second-quarter 2026 financial results on investor relations site
- PAYLOCITY HOLDING CORP : STIFEL RAISES TARGET PRICE TO $170 FROM $145
- Royalty Pharma Q2 GAAP net income attributable to company falls 44% to $18 million; non-GAAP adjusted EBITDA rises 16% to $736 million
- Kyndryl FY27 Q1 swings to net loss of $55 million; revenue falls 3% to $3.6 billion
- New York Times 2Q EPS $0.57 >NYT
- Vishay Intertechnology 2Q Rev $888.6M >VSH
- New York Times 2Q Adj EPS $0.69 >NYT
- Dine Brands Global 2Q Applebee's Comparable Domestic Same-Restaurant Sales Down 1.8% >DIN
- Spire Inc Backs FY Adj EPS $3.90-Adj EPS $4.10 >SR
- Dine Brands Global 2Q IHOP's Comparable Domestic Same-Restaurant Sales Up 1.5% >DIN
- Vishay Intertechnology 2Q Net $28.1M >VSH
- Q32 Bio 2Q Research and Development Expenses $4.3M >QTTB
- GlobalFoundries 2Q Adj EPS 46c >GFS
- Astec Industries 2Q Adj EPS 94c >ASTE
- Shake Shack 2Q EPS 37c >SHAK
- Shake Shack 2Q Adj EPS 43c >SHAK
- Shake Shack 2Q Rev $417.6M >SHAK
- US MBA Mortgage Survey Table Of Seasonally Adjusted Data
- Natural Resource Partners 2Q EPS $1.85 >NRP
- Natural Resource Partners 2Q Net $25.2M >NRP
- Hagerty 2Q Adj Loss/Shr 2c >HGTY
- Hagerty 2Q Rev $354.8M >HGTY
- Uber Technologies 2Q Delivery Gross Bookings $27.46B >UBER
- Uber Technologies 2Q Mobility Gross Bookings Up 22% >UBER
- Uber Technologies 2Q Mobility Gross Bookings $28.99B >UBER
- Uber Technologies 2Q Monthly Active Platform Consumers 208M >UBER
- Global Payments 2Q EPS 5c >GPN
- Global Payments 2Q Rev $3.32B >GPN
- Uber Technologies 2Q Trips 3.9B >UBER
- Elon Musk Has Lost the Midas Touch as AI Spending Booms -- Barrons.com
- Eli Lilly 2Q Revenue in the U.S. Increased 33% to $14.4 B >LLY
- Eos Energy Enterprises Sees FY Rev $300M-$350M >EOSE
- CVS Health 2Q Healthcare Benefits Segment Revenue Up 3.5% >CVS
- CVS Health Sees FY Adj EPS $7.90-Adj EPS $8.10 >CVS
- CVS Health Sees FY EPS $6.84-EPS $7.04 >CVS
- CVS Health Sees FY Net $8.81B-Net $9.07B >CVS
- CVS Health 2Q Health Services Segment Revenue Up 11.5% >CVS
